Synopsis: Gastrointestinal lymphomas;Les lymphomes gastro-intestinaux

Gastroenterologie Clinique et Biologique

Volumn 26, Issue 3, 2002, Pages 233-241

  Ruskoné Fourmestraux, Agnès ^a   Lavergne Slove, Anne ^b   Delmer, Alain ^a  

^a HÔTEL DIEU   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE SULFATE;

CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; DIGESTIVE SYSTEM CANCER; HUMAN; INTESTINE LYMPHOMA; REVIEW; STOMACH LYMPHOMA;

GASTROINTESTINAL NEOPLASMS; HUMANS; LYMPHOMA; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL;

EID: 0036117864     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Gastrointestinal lymphomas of T- and B-cell types
2. Gastrointestinal lymphomas: An overview with emphasis on new findings and diagnostic problems
3. Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry
4. Gastrointestinal lymphoma: Prevention and treatment of early lesions
5. Extranodal lymphomas
6. World Health Organization Classification of tumours
7. Classifying primary gut lymphomas
8. Multiple lymphomatous polyposis of the gastrointestinal tract: Prospective clinicopathologic study of 31 cases
9. Primary non-Hodgkin lymphoma of the stomach: Endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept
10. Lymphomes non-Hodgkiniens du tube digestif
11. Primary gastric non-Hodgkin's lymphoma: Requirements for diagnosis and staging
12. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy
13. Ongoing immunoglobulin gene mutations in mantle cell lymphomas
14. Histological grading in gastric lymphoma: Pretreatment criteria and clinical relevance
15. Primary gastric B-cell lymphoma: Results of a prospective multicenter study
16. Primary digestive tract lymphoma: A prospective multicentric study of 91 patients
17. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients
18. Endoscopic ultrasonography in the local staging of primary gastric lymphoma
19. Clinical staging classification of non-Hodgkin's lymphomas (author's transl)
20. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
21. Cure of Helicobacter pylori infection and duration of remission of low- grade gastric mucosa-associated lymphoid tissue lymphoma
22. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: A study controlled by endoscopic ultrasonography
23. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma
24. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue
25. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment
26. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: Histology, polymerase chain reaction, or both?
27. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial
28. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up
29. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori
30. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging
31. Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies
32. Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa- associated lymphoid tissue B-cell lymphoma
33. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa- associated lymphoid tissue lymphoma with prominent gastric expression
34. Management of stage IE primary gastric lymphoma
35. Mucosa-associated lymphoid tissue lymphoma of the stomach: Long term outcome after local treatment
36. Treatment of primary gastric lymphoma: Experience in the National Cancer Center Hospital, Tokyo
37. Management and long-term results of surgery for localized gastric lymphomas
38. Primary gastric non-Hodgkin's lymphoma localized to the gastric wall: No adjuvant treatment following radical surgery
39. Lymphomes gastro-intestinaux
40. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone
41. Stage I and II MALT lymphoma: Results of treatment with radiotherapy
42. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: Factors relevant to prognosis
43. Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor Stages IE and IIE
44. Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma-results of the prospective German Multicenter Study GIT NHL 01/92
45. Classification of intestinal T-cell neoplasms and their differential diagnosis
46. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma
47. Maladie coeliaque de l'adulte
48. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas